Epstein-Barr Virus (EBV-gp125 VCA) Conc. Ag

Concentrated Epstein-Barr Virus capsid antigen preparation from Antibodies.com, supplied in a 1 ml liquid format for use as a coating or capture reagent in immunoassay workflows. The gp125 VCA polypeptide is the major immunodominant glycoprotein component of the EBV virion and is broadly used in serological testing to evaluate prior exposure and current infection status. Researchers studying EBV-associated conditions including infectious mononucleosis, lymphoproliferative disorders, and nasopharyngeal carcinoma rely on this antigen for antibody screening by ELISA and related methods. The concentrated liquid formulation allows flexible dilution to optimize plate-coating density and minimize background in diagnostic or research settings. Each batch is generated under controlled conditions to support reproducible performance across runs. Handle using standard laboratory precautions for biosafety level 2 materials, store refrigerated, and reserve for research use only.